Cytokinetics share price
WebApr 6, 2024 · Cytokinetics initiated with buy rating, $60 price target at Truist Dec. 20, 2024 at 7:41 a.m. ET by Steve Gelsi Cytokinetics started at buy with $80 stock price target at … WebApr 12, 2024 · Oppenheimer cut their target price on shares of Cytokinetics from $55.00 to $54.00 and set an “outperform” rating for the company in a research note on Wednesday, March 1st.
Cytokinetics share price
Did you know?
WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate Web2 days ago · The Cytokinetics stock price fell by -3.54% on the last day (Wednesday, 12th Apr 2024) from $35.30 to $34.05. During the last trading day the stock fluctuated 5.99% from a day low at $33.88 to a day high of $35.91. The price has been going up and down for this period, and there has been a -2.66% loss for the last 2 weeks.
WebApr 11, 2024 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Cytokinetics stock is Moderate Buy based on the current 1 hold rating and 11 buy ratings for CYTK. The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00. WebIn terms of dividends, Cytokinetics Inc has a dividend per share of 0 and a dividend yield of 0. The company's most recent dividend date was None, and the ex-dividend date was None. CYTK's financials reveal a book value of -1.138 and earnings per share (EPS) of -4.16, with a diluted EPS (TTM) of -4.16.
WebLeading the group were shares of Cytokinetics (CYTK), up about 32.9% and shares of Sunesis Pharmaceuticals (SNSS) up about 16.1% on the day. WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cytokinetics Inc’s P/E ratio is -8.23.
WebGet the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …
WebApr 5, 2024 · 12 Wall Street research analysts have issued 12-month price objectives for Cytokinetics' shares. Their CYTK share price forecasts range from $15.00 to $80.00. … the post music venueWebCYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets Tech Media Success Video Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes 35.31 BATS BZX Real … siemens book a repairWebApr 11, 2024 · The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00. Do Wall Street analysts like … siemens bonus historyWebFeb 24, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 442% in the last half decade, a handsome return for long term holders. And this is just one example of the epic gains achieved by some long term investors. On the other hand, the stock price has retraced 5.7% in the last week. siemens bosch silence wtl 5600WebNov 8, 2024 · The cap price of the capped call transactions will initially be approximately $14.07 per share, which represents a premium of approximately 70% over the per share closing price of Cytokinetics’s ... siemens bluetooth hearing aids costWebFind real-time CYTK - Cytokinetics Inc stock quotes, company profile, news and forecasts from CNN Business. CYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets siemens bluetooth hearing aid pairingWebApr 10, 2024 · Cytokinetics (Nasdaq:CYTK) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Cytokinetics NasdaqGS:CYTK … siemens bluetooth hearing aid